BridgeBio Pharma, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Sep 2026Filed 29/10/2026 | Jun 2026Filed 10/08/2026 | Mar 2026Filed 07/05/2026 | Sep 2025Filed 29/10/2026 | Jun 2025Filed 10/08/2026 | Mar 2025Filed 07/05/2026 | Sep 2024Filed 29/10/2025 | Jun 2024Filed 05/08/2025 |
|---|---|---|---|---|---|---|---|---|
| $353 | $244 | $195 | $121 | $111 | $117 | $2.7 | $2.2 | |
| −$57 | −$152 | −$164 | −$183 | −$182 | −$167 | −$162 | −$73 | |
| −$0.42 | −$0.78 | −$0.84 | −$0.95 | −$0.95 | −$0.88 | −$0.86 | −$0.39 | |
| 196 | 196 | 195 | 192 | 191 | 190 | 189 | 188 |
Trend